Urethritis screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
! style="background: #FFE4B5; width: 500px;" | {{fontcolor|#8B0000|Recommendations}} | ! style="background: #FFE4B5; width: 500px;" | {{fontcolor|#8B0000|Recommendations}} | ||
|- | |- | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #FFFFE0;" | '''Women''' | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #FAFAD2;" | | ||
* Sexually active women under 25 years of age | * Sexually active women under 25 years of age | ||
* Sexually active women age 25 years and older if at increased risk | * Sexually active women age 25 years and older if at increased risk | ||
* Retest 3 months after treatment. | * Retest 3 months after treatment. | ||
|- | |- | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #FFFFE0;" | '''Men''' | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #FAFAD2;" | | ||
*Consider screening young men in high prevalence clinical settings or in populations with high burden of infection(e.g.Men who have sex with men) | *Consider screening young men in high prevalence clinical settings or in populations with high burden of infection(e.g.Men who have sex with men) | ||
|- | |- | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #FFFFE0;" | '''Pregnant women''' | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #FAFAD2;" | | ||
*All pregnant women under 25 years of age | *All pregnant women under 25 years of age | ||
*Pregnant women, aged 25 and older if at increased risk | *Pregnant women, aged 25 and older if at increased risk | ||
| Line 33: | Line 33: | ||
*Pregnant women with chlamydial infection should have a test-of-cure 3-4 weeks after treatment and be retested within 3 months | *Pregnant women with chlamydial infection should have a test-of-cure 3-4 weeks after treatment and be retested within 3 months | ||
|- | |- | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #FFFFE0;" | '''Men Who have Sex With Men (MSM) | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #FAFAD2;" | | ||
*At least annually for sexually active MSM at sites of contact (urethra, rectum) regardless of condom use | *At least annually for sexually active MSM at sites of contact (urethra, rectum) regardless of condom use | ||
*Every 3 to 6 months if at increased risk | *Every 3 to 6 months if at increased risk | ||
|- | |- | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #FFFFE0;" | '''HIV positive patients''' | ||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #FAFAD2;" | | ||
* For sexually active individuals, screen at first HIV evaluation, and at least annually | * For sexually active individuals, screen at first HIV evaluation, and at least annually | ||
* More frequent screening may be indicated depending on individual risk behaviors and the local epidemiology | * More frequent screening may be indicated depending on individual risk behaviors and the local epidemiology | ||
|} | |} | ||
Revision as of 17:58, 28 September 2016
|
Urethritis Microchapters | |
|
Diagnosis | |
|
Treatment | |
|
Case Studies | |
|
Urethritis screening On the Web | |
|
American Roentgen Ray Society Images of Urethritis screening | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
There is no recommendation for urethritis screening.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), screening for sexually transmitted disease is recommended as outlines below.
- Chlamydia Trachomatis
| Population | Recommendations |
|---|---|
| Women |
|
| Men |
|
| Pregnant women |
|
| Men Who have Sex With Men (MSM) |
|
| HIV positive patients |
|